Correlation Between Anebulo Pharmaceuticals and Exicure
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Exicure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Exicure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Exicure, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Exicure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Exicure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Exicure.
Diversification Opportunities for Anebulo Pharmaceuticals and Exicure
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Anebulo and Exicure is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Exicure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exicure and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Exicure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exicure has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Exicure go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Exicure
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Exicure. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 4.56 times less risky than Exicure. The stock trades about -0.17 of its potential returns per unit of risk. The Exicure is currently generating about 0.45 of returns per unit of risk over similar time horizon. If you would invest 233.00 in Exicure on August 25, 2024 and sell it today you would earn a total of 1,605 from holding Exicure or generate 688.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Exicure
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Exicure |
Anebulo Pharmaceuticals and Exicure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Exicure
The main advantage of trading using opposite Anebulo Pharmaceuticals and Exicure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Exicure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will offset losses from the drop in Exicure's long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Exicure vs. Ikena Oncology | Exicure vs. Eliem Therapeutics | Exicure vs. HCW Biologics | Exicure vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |